The Effects of Sertraline and Fluoxetine on Anxiety in the Elevated Plus-Maze Test
- 1 June 2000
- journal article
- Published by Walter de Gruyter GmbH in Journal of Basic and Clinical Physiology and Pharmacology
- Vol. 11 (2) , 173-180
- https://doi.org/10.1515/jbcpp.2000.11.2.173
Abstract
The aim of this study was to evaluate the acute and chronic effects of two SSRIs (sertraline and fluoxetine) on anxiety by the elevated plus-maze test. Diazepam increased the time spent in open arms significantly whereas the anxiogenic m-chlorophenylpiperazine (m-CPP) decreased the time significantly. Acute sertraline (10 mg x kg(-1)) and fluoxetine (20 mg x kg(-1)) treatment significantly decreased the time spent in open arms. Acute fluoxetine (20 mg x kg(-1)) treatment also decreased the total number of enclosed arm entries. Seven days sertraline treatment decreased the time spent in open arms, whereas 14 days fluoxetine treatment increased the time spent in open arms. These results show that acute administration of SSRIs may produce anxiogenic effects in the elevated plus-maze test.Keywords
This publication has 9 references indexed in Scilit:
- Animal models of ??anxiety??: where next?Behavioural Pharmacology, 1997
- Evidence that tolerance to the anxiogenic-like effects of mCPP does not involve alteration in the function of 5-HT2C receptors in the rat choroid plexusBehavioural Pharmacology, 1994
- Acute and chronic treatment with 5-HT reuptake inhibitors differentially modulate emotional responses in anxiety models in rodentsPsychopharmacology, 1994
- Effects of 5‐HT uptake inhibitors, agonists and antagonists on the burying of harmless objects by mice; a putative test for anxiolytic agentsBritish Journal of Pharmacology, 1991
- Modulation of baseline behavior in rats by putative serotonergic agents in three ethoexperimental paradigmsBehavioral and Neural Biology, 1990
- Effect of serotonergic lesion on “anxious” behaviour measured in the elevated plus-maze test in the ratPsychopharmacology, 1990
- Behavioral interactions of fluoxetine and other 5-hydroxytryptamine uptake inhibitors with ethanol in tests of anxiety, locomotion and explorationPsychopharmacology, 1988
- Fluoxetine, a Selective Serotonin Uptake Inhibitor, for the Treatment of Outpatients with Major DepressionJournal of Clinical Psychopharmacology, 1988